Introduction

Ca
2+ has a vital role in regulating diverse processes such as gene transcription, secretion, and contraction (1) . The transport of calcium is also critical in lactation, where calcium is a key requirement for neonatal nutrition (2) . Large quantities of calcium are transported from the maternal bloodstream into milk (3), which requires specialized transcellular pathways (2) .
Initially Ca 2+ must cross the basolateral membrane of mammary gland epithelial cells, before being transported across the epithelial cell, and into the lumen of the mammary alveoli (2) .
Although over recent years our understanding of the specific calcium ATPase (calcium pump)
isoforms involved in the secretory pathway and apical transport of Ca 2+ during lactation has increased, little is known about the channels involved in the transport of Ca 2+ into mammary epithelial cells during lactation. Regulation of these calcium channels is important since the epithelial cell must ensure that most of the Ca 2+ entering via these channels is functionally inert (i.e., the calcium ions are passengers rather than signaling effectors), to maintain normal cellular homeostasis and avoid aberrant cell proliferation and/or cell death signaling.
Transport of Ca 2+ across the plasma membrane into sections of calcium stores close to the plasma membrane is one way this could be achieved.
Calcium channels expressed in mammary gland epithelial cells may have significance beyond calcium enrichment of milk, since loss of normal Ca 2+ homeostasis can produce subtle alterations in cellular functions, which may contribute diseases, including cancer (4, 5) .
Indeed, multiple Ca 2+ channels are deregulated in various cancers, including breast cancer (4).
The recently identified ORAI family of calcium channels has properties that make this class of calcium channel a potential influx mechanism for calcium during lactation and in Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited.
Author Manuscript Published OnlineFirst on January 11, 2011; DOI: 10.1158/1535-7163. tumorigenic pathways in breast cancer cells (5, 6) . There are three ORAI calcium channels in humans (ORAI1-3) (7, 8) , with ORAI1 the most extensively characterized. The ORAI1 protein forms the pore subunit of the calcium influx pathway, which operates in response to endoplasmic reticulum Ca 2+ depletion (9, 10) , and this pathway is often referred to as storeoperated calcium influx. The endoplasmic reticulum Ca 2+ sensor, STIM1 is essential to the activation of this calcium influx pathway, as it responds to declines in endoplasmic reticulum store Ca 2+ by aggregating and interacting with apposed plasma membrane ORAI1 proteins,
causing ORAI1 to open (11) .
The ORAI family of calcium channels, and their classic regulators STIM1 and STIM2 (12),
have not been studied as potential mechanisms for calcium influx during lactation despite their association with the regulation of calcium stores. Recently, ORAI1-mediated calcium influx was linked to processes important in breast cancer metastasis (13) . Although storeoperated calcium entry is implicated in cancer cell proliferation and the regulation of calcium regulated transcription factors, no studies have assessed components of store-operated calcium influx in the context of breast cancer molecular subtypes, or disease prognosis.
In this study, we addressed the hypothesis that components of the ORAI-mediated calcium influx pathway are upregulated during lactation and contribute to calcium influx in mammary epithelial cells. We also addressed the hypothesis that specific components of the ORAI1-mediated calcium influx pathway are altered in some breast cancer cells and may be predictors of prognosis. Our data indicate that components of the ORAI1-mediated calcium influx pathway contribute to a novel mechanism of calcium influx in mammary epithelial cells during lactation and that this pathway is significant in breast cancer. 
Materials and Methods
Animals
Mammary gland from nulliparous animals was obtained from CBA x C57Bl6 mice at 14 weeks, ~day 10 of pregnancy, day 1 of lactation, and involution ~day 2 post-forced weaning (14) .
Cell culture
MCF-7 and MDA-MB-231 cell lines were originally obtained from ATCC and were maintained DMEM (Sigma Aldrich) with Penicillin G (100 U/mL; Invitrogen), streptomycin sulfate (100 g/mL; Invitrogen), 10% fetal bovine serum (FBS; Sigma Aldrich) and 4 mM Lglutamine (Invitrogen). The HC11 mouse mammary cell line was obtained from Dr Nancy Assay (Lonza Inc) and monitored for morphological characteristics. Where appropriate cell line characterization was performed through assessment of the levels of ERBB2, estrogen receptor, vimentin and E-cadherin using real time RT-PCR and/or immunohistochemistry. 7 RNA was isolated from the mouse mammary glands as described in Faddy et al (14) and from the cell lines using the RNeasy Plus Mini kit (Qiagen). RNA for ORAI comparative studies had been isolated previously as described (15) . RNA was reverse transcribed using the Omniscript® RT kit (Qiagen) followed by real time PCR using TaqMan® gene expression assays (Applied Biosystems) and TaqMan Universal PCR Master Mix. Assays included mouse Orai1, Orai2 and Orai3 (Mm00774349_m1, Mm01207170_m1, Mm01276333_m1), human ORAI1, ORAI2 and ORAI3 (Hs00385627_m1, Hs00259863_m1, Hs00743683_s1), mouse Trpc1 (Mm00441975_m1), mouse Stim1 and Stim2 (Mm00486423_m1, Mm01223102_m1) and human STIM1 and STIM2 (Hs00162394_m1, Mm01223102_m1), mouse -casein (Mm00839664_m1), and the endogenous control 18S rRNA. Thermal cycling was performed using a ABI PRISM 7500 Sequence Detector, at 50°C for 2 min, 95°C for 10 min, followed by 40 cycles at 95°C for 15 s and 60°C for 1 min. For all experiments mRNA levels were normalized to 18S rRNA and analyzed relative to the appropriate control (as described in the figure legends). Relative expression levels were calculated using the Ct method (17) .
RNA isolation and real time PCR
siRNA
All siRNAs used were Dharmacon ON-TARGETplus SMARTpools, which consist of a pool of four rationally designed siRNA sequences for each target gene. To reduce off-target effects, these siRNAs have dual strand modification (18) and use an algorithm to minimize seed region matches (19) 
MTS assay
Cell viability was determined 96 h after siRNA treatment or 72 h after incubation in the presence of 2-aminoethoxydiphenyl borate (2-APB; Sigma Aldrich) using the CellTiter 96®
AQueous One Solution Cell Proliferation Assay (MTS assay; Promega) (20) . After depletion of endoplasmic calcium, extracellular calcium (2 mM) was added.
Fluorescence was determined at 470-495 excitation and 515-575 emission.
STIM1 and STIM2 analysis in human breast tumors
A gene expression dataset consisting of the microarray profiles of 295 primary human breast tumors (21) (22) . One probe on the array (annotated as NM_003156) corresponded to STIM1 and one probe (annotated as KIAA1482) corresponded to STIM2. Tumors were divided into STIM1 or STIM2 "high" and "low" groups based on the median expression level of each gene in the cohort and chi-squared analysis was used to determine whether the balance of STIM1/2 differed significantly for any transcriptional subtype. Survival curves were computed using the method of Kaplan and Meier and statistical significance was evaluated using the log-rank test.
Statistical analysis
Statistical significance was assessed as described in the individual figure legends. Data analysis was performed using Prism version 5.02 for Windows (Graphpad Inc). 
Results
Orai1 calcium channels and mammary gland development.
Mammary gland development during pregnancy, lactation and involution is associated with alterations in the transcription of specific calcium ATPase isoforms, more specifically the pronounced upregulation of the secretory calcium ATPase isoform, Spca2, and the plasma membrane Ca 2+ -ATPase isoform, PMCA2 (14, 23, 24) . In this study we assessed mRNA levels of calcium channels Orai1, Orai2 and Orai3 and Trpc1 during mammary gland development. We show that mouse mammary gland development is associated with a significant upregulation of Orai1 calcium channels during lactation, with this upregulation reversed during involution (Fig. 1A) . In contrast, the related isoforms Orai2 and Orai3 were associated with a decline in levels during mammary gland development and their expression did not recover during the early stages of involution (Fig. 1B-C) . Given the reports of members of the transient receptor potential cation (TRPC) channel family contributing to store-operated calcium entry (25, 26) , we assessed Trpc1 levels during mammary gland development, and similarly to Orai2 and Orai3, no increase in Trpc1 was seen in lactation (Fig. 1D ). There were lower levels of Trpc1 during lactation and the early stages of involution (Fig. 1D) . Hence, a significant change in the transcription of calcium channels is associated with lactation, with pronounced upregulation of Orai1 in vivo. We also saw that in the HC11 mouse mammary epithelial cell in vitro model Orai1 levels modestly increased with culturing ( Fig 1E) .
ORAI1 but not ORAI2 and ORAI3 levels are altered in human breast cancer cell lines.
Given the association between proteins involved in mammary gland development and tumorigenesis pathways (15, 27) , the link between store-operated calcium influx and (Fig. 2A) . In contrast, levels of ORAI1 were elevated up to 21-fold in many of the breast cancer cell lines compared with the non-malignant mammary epithelial cell lines, with only the SK-BR-3 cell line having a less than 5-fold increase in transcription compared to 184A1 cells ( Fig. 2A) . ORAI1 was the predominant isoform in MCF-7, ZR-75-1, MDA-MB-231 and T-47D cell lines. To probe the potential of modulating the ORAI1 pathway therapeutically, we assessed the consequences of ORAI1 knockdown in two breast cancer cell lines that had elevated levels of ORAI1.
Knockdown of ORAI1 attenuates store-operated calcium entry, viable cell number and the response to an invasive stimuli.
ORAI1 knockdown using siRNA was achieved without pronounced effects on the related isoforms ORAI2 and ORAI3 in MCF-7 ( Fig. 2B ) and MDA-MB-231 (Fig. 2B ) breast cancer cells. To confirm functional knockdown was achieved, we assessed store-operated calcium influx in these cell lines. Store-operated calcium influx was induced through incubation of breast cancer cell lines with the sarco/endoplasmic reticulum Ca 2+ -ATPase (SERCA) inhibitor cyclopiazonic acid (CPA) in the absence of extracellular calcium to deplete the endoplasmic reticulum calcium store (28, 29) . Re-addition of extracellular calcium was associated with a pronounced influx of calcium in store depleted (CPA treated) cells in both cell lines compared to cells not treated with CPA ( Fig. 2C & D) . ORAI1 inhibition does not completely eliminate calcium influx associated with store depletion (Fig. 2C & D) . Our studies assessing calcium leak (calcium influx in the absence of a SERCA inhibitor) show that this remaining calcium of ORAI1 mRNA. ORAI1 levels may also be dependent on breast cancer subtype, with elevated levels in the basal breast cancers compared to other subtypes in microarray studies ( Fig 2E) .
We then assessed the consequence of inhibition of ORAI1-mediated store-operated calcium influx. ORAI1 siRNA significantly affected MCF-7 and MDA-MB-231 breast cancer cell lines (Fig. 3A) . Thus, although some non-ORAI1 store-operated calcium influx remains in ORAI1 siRNA treated cells (Fig. 2C & D) , ORAI1 inhibition in breast cancer cells is still sufficient to significantly affect breast cancer cells (Fig. 3A) . Pharmacological inhibition of store-operated calcium influx mediated by the non-specific inhibitor 2-APB was associated with a similar result (Fig. 3B) . To then determine in a pathophysiological context if ORAI1 inhibition could remodel the calcium signaling initiated by an invasive stimulus, MDA-MB-231 cells were treated with the PAR-2 receptor activator trypsin (30) . PAR-2 promotes the invasiveness of MDA-MB-231 cells (31) (32) (33) (34) and our studies show that ORAI1 inhibition reduces the calcium influx associated with this pathway (Fig. 3C & D) . The precise mechanisms involved in these phenotypes may be complex; our studies show that ORAI1 inhibition does not affect entry into the S phase of the cell cycle (Fig 3E) implicating later phases and/or alterations in viability or cellular adhesion. 
Orai1 calcium channel modulators Stim1 and Stim2 during mammary gland development
Given the increased levels of Orai1 during the lactation stage of mammary gland development, we assessed the endogenous regulators of Orai1, the calcium store sensor Stim1 and its isoform Stim2, in the context of lactation. Despite its well characterized association with Orai1 in store-operated calcium influx, levels of the Orai1 activator Stim1 did not increase during lactation, instead a significant decline was observed during pregnancy, lactation and early involution (Fig. 4A) . Assessment of the related isoform Stim2 showed that this isoform did not decline during lactation, and instead a modest, but statistically significant, increase in levels was observed (Fig. 4B ). This increase was reversed during early involution (as was the case for Orai1 during mammary gland development (Fig. 1A) ). line 184A1 (Fig. 5A) . Given the report of opposing effects of STIM1 and STIM2 on ORAI1-mediated calcium influx (38) , the ratio of the expression of these two genes was compared in breast cancer cell lines. The comparison between the relative levels of STIM1 and STIM2 indicated that the relative levels of STIM1 to STIM2 were similar in the breast cancer cell lines, with the exception of the ERBB2 overexpressing cell line SK-BR-3 (Fig. 5B) . The altered relative levels of STIM1 and STIM2 in SK-BR-3 cells did not appear to be a consequence of ERBB2 activity or expression, as neither treatment with the ERBB2 inhibitor AG825 (10 μM) in SK-BR-3 cells nor the activation of ERBB2 in MCF-7 cells with heregulin β1 (10 ng/ml) had a significant effect on the STIM1/STIM2 ratio (data not shown). Given the different roles and properties of STIM1 and STIM2 (35) , and the report that overexpression of STIM2 may have inhibitory effects on the STIM1 activation of ORAI1 (38) , and our own finding that some breast cancer cell lines are characterized by an alteration in the STIM1/STIM2 ratio, we explored further the significance of STIM1 and STIM2 expression levels in breast cancer.
We examined the distribution of STIM1 and STIM2 genes in the transcriptional profiles of 295 primary breast tumors previously reported by van de Vijver and colleagues (21) (Fig. 6A) .
In this dataset, comprised of tumors of several different transcriptional subtypes, there was no obvious correlation between STIM1 and STIM2 levels (r 2 = 0.0045). To determine whether an alteration in the balance between STIM1 and STIM2 might be indicative of one or more of the transcriptional classes of breast cancer (39), we assigned each tumor to the appropriate class based on its gene expression profiles ( 16 in this quadrant had significantly poorer outcomes than the other groups (Fig. 6C) . Tumors in the upper quartile of STIM1 expression also had significantly worse outcomes compared to other groups, as did tumors in the lowest quartile for STIM2 expression although these relationships were not as significant as a high STIM1; low STIM2 (data not shown).
Consistent with a potentially different role of STIM1 and STIM2 in breast cancer cells, STIM1 inhibition had a greater impact on store operated Ca 2+ influx in MDA-MB-231 cells than STIM2 inhibition (Fig 6D) . 
Discussion
A key component of the nutritional benefit of milk is calcium. Over recent years our understanding of how calcium is transported into milk from the mammary epithelial cell has become clearer (2) . Studies have highlighted the apical transport and the secretion of calcium during lactation (2, 14, 23, 24, 40, 41) , however, how calcium enters the mammary epithelial cell is not well understood (2, 27, 40) . No studies have identified a calcium influx pathway that has a pronounced upregulation during lactation. From our studies it appears that ORAI1 and its calcium store sensing regulator STIM2 are important components in the remodeling of calcium influx that occurs to meet the calcium transport demands of lactation. We also In the mammary gland during lactation there was a significant increase in Orai1 transcription with a reduction in Orai2 and Orai3. The ORAI isoforms differ in their calcium selectivity, conductance, and activation kinetics (42, 43) . TRPC1 is also implicated in store-operated calcium entry (25, 26) , in some cases with ORAI1 (44, 45), so we assessed its potential role in lactation. However, there are contradictory reports of the role of TRPC1 in store-operated calcium entry (46, 47) and our studies show that Trpc1 is unlikely to be associated with the Orai1-mediated calcium influx occurring during lactation, since there was a significant decline in its levels during lactation.
Despite the well-defined relationship between the endoplasmic reticulum calcium sensor STIM1, and ORAI1 activation (6, 7, 12) , lactation was associated with a pronounced and significant decline in Stim1. However, considering the differences between STIM1 and the isoform STIM2, the apparent contradiction of the modest rise in Stim2 and a decline in Stim1, suggests that this is well suited to the calcium homeostasis changes that occur during lactation. Brandman et al (35) , proposed that STIM1 activates ORAI1 only after pronounced endoplasmic reticulum calcium store depletion, whereas STIM2 is a key regulator of basal calcium influx, and does not require the pronounced depletion of endoplasmic reticulum calcium stores to activate ORAI1. STIM2 is therefore responsible for the "tight" regulation of resting calcium levels in the cytosol and intracellular calcium stores. Lactation is not associated with a pronounced decline in endoplasmic reticulum calcium levels (48) , and a sustained basal-like calcium influx, such as that regulated by STIM2, would be well suited to the supply of calcium for apical and secretory pathway transport. Indeed, basal calcium levels declined in the presence of Stim2 siRNA-mediated inhibition in HC11 mammary cells. A modest, rather than an order or magnitude increase, in STIM2 levels during lactation would avoid the potential inhibitory effects of STIM2 on ORAI1 activity (38) , which occurs with sustained high STIM2 overexpression (35) . It is likely that the relative levels of STIM1, recent demonstration that the calcium pump SPCA2, which is also increased during lactation, can directly activate ORAI (50) , is a further indication that there may be multiple mechanisms by which ORAI is activated independent of STIM1 during lactation and in disease Future studies using combinations of ORAI1, STIM1 and STIM2 selective knockdown in mammary gland epithelial cells in vivo and the measurement of milk Ca 2+ content are required to definitively define the significance of STIM2-mediated activation of ORAI1 in the enrichment of milk with calcium.
Our studies indicate that ORAI1 elevation is a feature of some breast cancer cell lines. Our work also shows that ORAI1-mediated calcium influx, facilitated by calcium store depletion is present in multiple breast cancer cell lines and calcium leak (calcium influx in the absence of store depletion) is modest. Despite the presence of other ORAI isoforms, selective inhibition of ORAI1 is sufficient to alter breast cancer cell properties and the nature of the calcium influx associated with growth factors and pro-invasiveness stimuli associated with calcium store mobilization, such as seen in our studies with a PAR-2 activator. PAR-2 is a G- from three independent experiments. *P < 0.001 using a one-way ANOVA with a Bonferroni multiple comparison post-test to compare NT siRNA with ORAI1 siRNA for each cell line.
B) ORAI1 was inhibited using the non-specific calcium channel antagonist 2-APB and cell growth compared to control using an MTS assay. Data are mean ± SEM (N = 8) from two independent experiments. *P < 0.001 compared to control using a two tailed unpaired t-test. 
